Streetbeat News

Products Services

TENX

Tenax Therapeutics has been granted a new US patent for the use of Levosimendan in treating pulmonary hypertension associated with heart failure with preserved ejection fraction, extending its protections until December 2040.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:33 am

CATX

The FDA has chosen Perspective Therapeutics to join the CDRP program, aiming to accelerate the development readiness of VMT-α-NET for treating neuroendocrine tumors. This selection could significantly impact the company's progress in bringing its treatment to market sooner.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:20 am

TSLA

Tesla, Inc. (NASDAQ:TSLA) experienced a significant stock surge, increasing by $25.76 or 15.31%, closing at $194.05. The rise was humorously celebrated by Elon Musk and investor Sawyer Merritt, referencing critic Gordon Johnson's low price target. Despite the surge, Johnson remains skeptical, particularly about Tesla's advancements in China and the challenges of data localization and U.S. restrictions on NVDA chip shipments.

Portfolio Pulse from Shanthi Rexaline

April 30, 2024 | 11:20 am

YELP

Yelp has announced its spring product release, introducing a new AI-powered Yelp Assistant designed to enhance user experience by providing more personalized and efficient service.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:20 am

GRTS

Gritstone Bio presented data at ESCMID Global 2024 showcasing the durability and broad utility of its self-amplifying mRNA COVID-19 vaccine, indicating potential for widespread application and long-term effectiveness.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:16 am

ACB

Aurora has expanded its product line in Australia by introducing a new range of premium dried flower products, aiming to strengthen its market presence.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:16 am

HRMY

Harmony Biosciences acquires Epygenix Therapeutics for $35M, with potential development and sales milestone payments totaling $645M. EPX-100, their lead candidate for rare epilepsy conditions, is in a pivotal trial with topline data expected in 2026, indicating a significant market opportunity.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:14 am

GIS

General Mills (GIS) has announced the acquisition of Edgard & Cooper, expanding its pet food portfolio as part of its Accelerate strategy. This move is aimed at enhancing General Mills' position in the fast-growing pet food market, leveraging Edgard & Cooper's unique brand and product offerings.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:10 am

VERI

Veritone, Inc. (VERI) has partnered with OPEXUS to deliver artificial intelligence solutions to a major national Canadian bank. This collaboration aims to enhance the bank's operational efficiency and customer service through advanced AI technologies.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:09 am

PLBY

Playboy has announced the signing of multiple new license agreements in China, aiming to expand its brand presence and product offerings in the Chinese market. These agreements are expected to enhance Playboy's visibility and revenue potential in one of the world's largest consumer markets.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:08 am